Fulcrum Therapeutics, Inc. ( NASDAQ: FULC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Alex Sapir – President and Chief Executive Officer Alan Musso – Chief Financial Officer Iain Fraser – ...

A Bahrain study shows CT scans to check for blood clots in lung blood vessels increased significantly in people with sickle ...

This week's Guest Voice is Richard Bayliss, who talks about three coping tools he's found useful in living with sickle cell ...

Enrollment complete in the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD); initiated the 20 mg dose cohort ― ― On track to provide clinical data from ...